Balance Sheet Sandoz Group AG

Stocks

SDZ

CH1243598427

Pharmaceuticals

Market Closed - Swiss Exchange Other stock markets 09:00:31 21/07/2026 pm IST			5-day change	1st Jan Change
66.54 ^CHF	+2.43%		-0.18%	+15.04%

21/07	Novartis Returns to Growth After Key Drugs Offset Patent Expirations -- Update	DJ
16/07	Sandoz Group AG Announces Management Changes	CI

40d8.Q3vmXUDQWpzgF4ff10dWycrmWjkFXrzA8QEeQVVBcFU.EDrQHymDbci0RN2AknZgn56wLFB_NOSwlmhMMB05O2QqF5M_GKcQ_4hTtw

Published financial data: SANDOZ GROUP AG

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	961.9Cr	927.6Cr	994.9Cr	1.04TCr	1.11TCr
Other Revenues, Total	5.9Cr	3Cr	3Cr	2.7Cr	7.1Cr
Total Revenues	967.8Cr	930.6Cr	997.9Cr	1.04TCr	1.12TCr
Cost of Goods Sold, Total	507.9Cr	492.8Cr	541.5Cr	545.8Cr	585.7Cr
Gross Profit	459.9Cr	437.8Cr	456.4Cr	492.6Cr	530Cr
Selling General & Admin Expenses, Total	212.7Cr	212.7Cr	238.9Cr	243.3Cr	252.9Cr
R&D Expenses	91Cr	83Cr	93Cr	93Cr	104.8Cr
Other Operating Expenses	17Cr	18Cr	87Cr	125.4Cr	28Cr
Other Operating Expenses, Total	320.5Cr	313.9Cr	418.9Cr	461.9Cr	385.5Cr
Operating Income	139.4Cr	123.9Cr	38Cr	31Cr	144.5Cr
Interest Expense, Total	-6.5Cr	-8.9Cr	-20Cr	-25Cr	-22Cr
Interest And Investment Income	50L	80L	3.1Cr	4.3Cr	4.7Cr
Net Interest Expenses	-6Cr	-8.1Cr	-17Cr	-21Cr	-17Cr
Currency Exchange Gains (Loss)	-1.6Cr	-3.2Cr	-6.1Cr	-9.2Cr	1Cr
Other Non Operating Income (Expenses)	-50L	-60L	-30L	-2.2Cr	-4.3Cr
EBT, Excl. Unusual Items	131.3Cr	112Cr	14Cr	-1.5Cr	123.9Cr
Asset Writedown	-	-	-	-	-1.8Cr
Other Unusual Items	-	-1.8Cr	-1Cr	40L	-1.4Cr
EBT, Incl. Unusual Items	131.3Cr	110.2Cr	13Cr	-1.1Cr	120.7Cr
Income Tax Expense	40Cr	25Cr	5Cr	-1.2Cr	29Cr
Earnings From Continuing Operations	91Cr	85Cr	8Cr	10L	91Cr
Net Income to Company	91Cr	85Cr	8Cr	10L	91Cr
Minority Interest	-20L	-20L	-30L	-10L	-
Net Income - (IS)	91Cr	85Cr	7.7Cr	0	91Cr
Net Income to Common Incl Extra Items	91Cr	85Cr	7.7Cr	0	91Cr
Net Income to Common Excl. Extra Items	91Cr	85Cr	7.7Cr	0	91Cr
Per Share Items
Net EPS - Basic	-	-	0.18	-	2.12
Basic EPS - Continuing Operations	-	-	0.18	-	2.12
Basic Weighted Average Shares Outstanding	-	-	43Cr	43Cr	43Cr
Net EPS - Diluted	-	-	0.18	-	2.09
Diluted EPS - Continuing Operations	-	-	0.18	-	2.09
Diluted Weighted Average Shares Outstanding	-	-	43Cr	43Cr	44Cr
Normalized Basic EPS	-	-	0.2	-0.02	1.79
Normalized Diluted EPS	-	-	0.2	-0.02	1.77
Dividend Per Share	-	-	0.53	0.66	1.01
Payout Ratio	-	-	-	-	34.46
American Depositary Receipts Ratio (ADR)	1	1	1	1	1
Supplemental Items
EBITDA	184Cr	166Cr	79Cr	73Cr	189.2Cr
EBITA	163Cr	146.1Cr	60Cr	56Cr	169.3Cr
EBIT	139.4Cr	123.9Cr	38Cr	31Cr	144.5Cr
Effective Tax Rate - (Ratio)	30.69	22.87	38.46	109.09	24.28
Total Current Taxes	42Cr	28Cr	9.3Cr	22Cr	32Cr
Total Deferred Taxes	-1.5Cr	-3Cr	-4.3Cr	-23Cr	-2.4Cr
Normalized Net Income	82Cr	70Cr	8.45Cr	-1.04Cr	77Cr
Interest Capitalized	20L	30L	30L	10L	30L
Interest on Long-Term Debt	90L	1.3Cr	1.5Cr	2.1Cr	2.2Cr
Supplemental Operating Expense Items
Research And Development Expense From Footnotes	97Cr	88Cr	97Cr	96Cr	106.3Cr
Stock-Based Comp., Other (Total)	6.9Cr	6.6Cr	8.3Cr	8.8Cr	10Cr
Total Stock-Based Compensation	6.9Cr	6.6Cr	8.3Cr	8.8Cr	10Cr

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	4Cr	7.4Cr	110.9Cr	119.1Cr	173.9Cr
Total Cash And Short Term Investments	4Cr	7.4Cr	110.9Cr	119.1Cr	173.9Cr
Accounts Receivable, Total	220.7Cr	229.8Cr	261.5Cr	220.5Cr	250.8Cr
Other Receivables	118.8Cr	134.5Cr	92Cr	136.3Cr	75Cr
Total Receivables	339.5Cr	364.3Cr	353.5Cr	356.8Cr	325.9Cr
Inventory	200.6Cr	212.4Cr	270Cr	280Cr	284.5Cr
Prepaid Expenses	12Cr	13Cr	14Cr	22Cr	30Cr
Other Current Assets, Total	30L	10L	9.3Cr	2.1Cr	1.9Cr
Total Current Assets	556.5Cr	597.6Cr	757.2Cr	780.1Cr	816.5Cr
Gross Property Plant And Equipment	524.5Cr	508Cr	429.5Cr	424.7Cr	543.4Cr
Accumulated Depreciation	-331.2Cr	-317.6Cr	-244.5Cr	-225.9Cr	-265.4Cr
Net Property Plant And Equipment	193.3Cr	190.4Cr	185Cr	198.8Cr	278Cr
Long-term Investments	1.9Cr	1.5Cr	2.1Cr	2.4Cr	2.2Cr
Goodwill	768.3Cr	743.7Cr	758.9Cr	746.9Cr	801.4Cr
Other Intangibles, Total	158.1Cr	145.4Cr	156.2Cr	147.5Cr	186.7Cr
Loans Receivable Long-Term	90L	1.1Cr	1.4Cr	1.1Cr	1.5Cr
Deferred Tax Assets Long-Term	72Cr	71Cr	72Cr	95Cr	92Cr
Other Long-Term Assets, Total	3.5Cr	4.7Cr	11Cr	18Cr	24Cr
Total Assets	1.75TCr	1.76TCr	1.94TCr	1.99TCr	2.2TCr
Liabilities
Accounts Payable, Total	117.3Cr	135.7Cr	159.3Cr	151.9Cr	185Cr
Accrued Expenses, Total	63Cr	67Cr	86Cr	95Cr	111.1Cr
Short-term Borrowings	462.9Cr	385.1Cr	-	-	-
Current Portion of Long-Term Debt	16Cr	18Cr	28Cr	14Cr	61Cr
Current Portion of Leases	3.4Cr	3.1Cr	5.4Cr	5.8Cr	7Cr
Current Income Taxes Payable	20Cr	23Cr	57Cr	51Cr	65Cr
Unearned Revenue Current, Total	40L	30L	80L	40L	1.3Cr
Other Current Liabilities	153.3Cr	158.5Cr	233Cr	312.1Cr	258.9Cr
Total Current Liabilities	836.5Cr	791.4Cr	569.8Cr	630.7Cr	689.5Cr
Long-Term Debt	1.7Cr	3Cr	397.5Cr	439Cr	470Cr
Long-Term Leases	10Cr	8.8Cr	26Cr	28Cr	32Cr
Pension & Other Post Retirement Benefits	33Cr	24Cr	26Cr	27Cr	30Cr
Deferred Tax Liability Non Current	29Cr	29Cr	25Cr	26Cr	21Cr
Other Non Current Liabilities	27Cr	24Cr	34Cr	24Cr	23Cr
Total Liabilities	937.9Cr	879.7Cr	1.08TCr	1.17TCr	1.26TCr
Common Stock, Total	-	-	2.4Cr	2.5Cr	2.5Cr
Retained Earnings	825.7Cr	892Cr	805.8Cr	790.8Cr	862Cr
Treasury Stock	-	-	-	-10L	-10L
Comprehensive Income and Other	-10Cr	-17Cr	56Cr	23Cr	74Cr
Total Common Equity	815.3Cr	874.8Cr	864.5Cr	816.3Cr	938.4Cr
Minority Interest	1Cr	1.2Cr	90L	10L	10L
Total Equity	816.3Cr	876Cr	865.4Cr	816.4Cr	938.5Cr
Total Liabilities And Equity	1.75TCr	1.76TCr	1.94TCr	1.99TCr	2.2TCr
Supplemental Items
ECS Total Shares Outstanding on Filing Date	-	-	43Cr	43Cr	43Cr
ECS Total Common Shares Outstanding	-	-	43Cr	43Cr	43Cr
Book Value / Share	-	-	20.12	18.95	21.69
Tangible Book Value	-111.1Cr	-14Cr	-51Cr	-78Cr	-50Cr
Tangible Book Value Per Share	-	-	-1.18	-1.81	-1.15
Total Debt	494.1Cr	418.5Cr	456.8Cr	486.9Cr	569.9Cr
Net Debt	490.1Cr	411.1Cr	345.9Cr	367.8Cr	396Cr
Debt Equivalent of Unfunded Proj. Benefit Obligation	24Cr	14Cr	19Cr	18Cr	20Cr
Minority Interest, Total (Incl. Fin. Div)	1Cr	1.2Cr	90L	10L	10L
Account Code - Inventory Valuation	-	5	5	5	5
Inventories - Raw Materials, Total	15Cr	17Cr	21Cr	19Cr	20Cr
Inventories - Work In Process, Total	50Cr	64Cr	99Cr	97Cr	96Cr
Inventories - Finished Goods, Total	135.7Cr	131.5Cr	186.4Cr	195.9Cr	203.3Cr
Land - (BS)	11Cr	9.9Cr	6.9Cr	6.5Cr	12Cr
Buildings, Total	150.3Cr	140.3Cr	101.1Cr	96Cr	117.5Cr
Machinery, Total	320.5Cr	308.4Cr	251.8Cr	248Cr	298.9Cr
Full Time Employees	-	21.74T	22.63T	22.05T	22.36T
Accumulated Allowance for Doubtful Accounts (Supple)	2.3Cr	1.6Cr	2.5Cr	2.1Cr	2.2Cr

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	91Cr	85Cr	7.7Cr	10L	91Cr
Depreciation & Amortization - CF	25Cr	24Cr	24Cr	24Cr	28Cr
Amortization of Goodwill and Intangible Assets - (CF)	24Cr	22Cr	23Cr	25Cr	25Cr
Depreciation & Amortization, Total	49Cr	46Cr	47Cr	49Cr	52Cr
(Gain) Loss From Sale Of Asset	-3.4Cr	-2.4Cr	-1Cr	-5.6Cr	-2.2Cr
Asset Writedown & Restructuring Costs	3.6Cr	3.4Cr	5.7Cr	1Cr	2.1Cr
Stock-Based Compensation (CF)	-	-	2.5Cr	8.8Cr	10Cr
Other Operating Activities, Total	-38Cr	-5.7Cr	41Cr	49Cr	-81Cr
Change In Accounts Receivable	-5.2Cr	-18Cr	-39Cr	26Cr	-10Cr
Change In Inventories	18Cr	-27Cr	-58Cr	-28Cr	23Cr
Change In Accounts Payable	9.3Cr	13Cr	51Cr	2.5Cr	2.8Cr
Change in Other Net Operating Assets	11Cr	29Cr	-20Cr	-37Cr	71Cr
Cash from Operations	135.4Cr	122.3Cr	36Cr	66Cr	159.4Cr
Capital Expenditure	-31Cr	-28Cr	-36Cr	-40Cr	-49Cr
Sale of Property, Plant, and Equipment	2.8Cr	90L	3.4Cr	2.6Cr	70L
Cash Acquisitions	-37Cr	-3.2Cr	-1.6Cr	-19Cr	-26Cr
Divestitures	1.2Cr	-70L	-20L	60L	-
Sale (Purchase) of Intangible assets	-4.1Cr	-12Cr	-26Cr	-18Cr	-26Cr
Investment in Marketable and Equity Securities, Total	-10L	-50L	-30L	-30L	-20L
Other Investing Activities, Total	-20L	-	-70L	-10L	3.3Cr
Cash from Investing	-69Cr	-43Cr	-61Cr	-74Cr	-98Cr
Short Term Debt Issued, Total	2.3Cr	4.3Cr	12Cr	-	-
Long-Term Debt Issued, Total	1.6Cr	1.6Cr	644.9Cr	75Cr	99Cr
Total Debt Issued	3.9Cr	5.9Cr	657Cr	75Cr	99Cr
Short Term Debt Repaid, Total	-	-	-	-11Cr	-3.8Cr
Long-Term Debt Repaid, Total	-4.3Cr	-3.7Cr	-266.9Cr	-14Cr	-83Cr
Total Debt Repaid	-4.3Cr	-3.7Cr	-266.9Cr	-25Cr	-87Cr
Repurchase of Common Stock	-	-	-	-1.2Cr	-
Common Dividends Paid	-	-	-	-22Cr	-32Cr
Common & Preferred Stock Dividends Paid	-	-	-	-22Cr	-32Cr
Other Financing Activities, Total	-65Cr	-79Cr	-265.9Cr	-3.1Cr	-40L
Cash from Financing	-66Cr	-77Cr	124.2Cr	24Cr	-20Cr
Foreign Exchange Rate Adjustments	-50L	1Cr	4.5Cr	-7.6Cr	13Cr
Net Change in Cash	10L	3.4Cr	103.5Cr	8.2Cr	55Cr
Supplemental Items
Cash Interest Paid	6.2Cr	8Cr	16Cr	20Cr	19Cr
Cash Income Tax Paid (Refund)	48Cr	27Cr	24Cr	26Cr	22Cr
Levered Free Cash Flow	66Cr	77Cr	99Cr	63Cr	92Cr
Unlevered Free Cash Flow	71Cr	83Cr	111.74Cr	79Cr	106.21Cr
Change In Net Working Capital	37Cr	7.4Cr	-95Cr	-60Cr	-29Cr
Net Debt Issued / Repaid	-40L	2.2Cr	390.1Cr	50Cr	12Cr

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	4.91	4.41	1.27	0.98	4.31
Return on Total Capital	6.67	5.95	1.79	1.46	6.42
Return On Equity %	11.46	10.05	0.92	0.01	10.42
Return on Common Equity	11.44	10.03	0.89	0	10.42
Margin Analysis
Gross Profit Margin %	47.52	47.04	45.74	47.44	47.5
SG&A Margin	21.98	22.86	23.94	23.43	22.67
EBITDA Margin %	19.01	17.84	7.96	7.07	16.96
EBITA Margin %	16.84	15.7	6.06	5.38	15.17
EBIT Margin %	14.4	13.31	3.76	2.96	12.95
Income From Continuing Operations Margin %	9.4	9.13	0.8	0.01	8.19
Net Income Margin %	9.38	9.11	0.77	0	8.19
Net Avail. For Common Margin %	9.38	9.11	0.77	0	8.19
Normalized Net Income Margin	8.46	7.5	0.85	-0.1	6.94
Levered Free Cash Flow Margin	6.87	8.31	9.93	6.09	8.29
Unlevered Free Cash Flow Margin	7.29	8.91	11.2	7.6	9.52
Asset Turnover
Asset Turnover	0.55	0.53	0.54	0.53	0.53
Fixed Assets Turnover	4.83	4.85	5.32	5.41	4.68
Receivables Turnover (Average Receivables)	4.33	4.12	4.05	4.3	4.7
Inventory Turnover (Average Inventory)	2.33	2.39	2.25	1.98	2.08
Short Term Liquidity
Current Ratio	0.67	0.76	1.33	1.24	1.18
Quick Ratio	0.41	0.47	0.82	0.75	0.72
Operating Cash Flow to Current Liabilities	0.16	0.15	0.06	0.1	0.23
Days Sales Outstanding (Average Receivables)	84.28	88.63	90.12	85.17	77.59
Days Outstanding Inventory (Average Inventory)	156.52	152.95	162.58	184.41	175.89
Average Days Payable Outstanding	87.38	91.5	89.86	102.46	104.18
Cash Conversion Cycle (Average Days)	153.42	150.08	162.84	167.11	149.31
Long Term Solvency
Total Debt/Equity	60.53	47.77	52.78	59.64	60.72
Total Debt / Total Capital	37.71	32.33	34.55	37.36	37.78
LT Debt/Equity	1.47	1.35	48.88	57.15	53.44
Long-Term Debt / Total Capital	0.92	0.91	31.99	35.8	33.25
Total Liabilities / Total Assets	53.47	50.11	55.46	58.99	57.4
EBIT / Interest Expense	21.45	13.92	1.86	1.22	6.57
EBITDA / Interest Expense	28.97	19.07	4.17	3.18	8.95
(EBITDA - Capex) / Interest Expense	24.15	15.94	2.37	1.57	6.71
Total Debt / EBITDA	2.62	2.47	5.42	6.09	2.89
Net Debt / EBITDA	2.6	2.42	4.1	4.6	2.01
Total Debt / (EBITDA - Capex)	3.15	2.95	9.54	12.33	3.86
Net Debt / (EBITDA - Capex)	3.12	2.9	7.22	9.31	2.68
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	0.21	-3.84	7.23	4.06	7.44
Gross Profit, 1 Yr. Growth %	3.14	-4.81	4.25	7.93	7.42
EBITDA, 1 Yr. Growth %	26.9	-9.78	-52.17	-7.56	162.78
EBITA, 1 Yr. Growth %	39.08	-10.37	-58.59	-7.6	210.64
EBIT, 1 Yr. Growth %	73.82	-11.12	-69.73	-18.13	393.17
Earnings From Cont. Operations, 1 Yr. Growth %	96.12	-6.59	-90.59	-98.75	91.3T
Net Income, 1 Yr. Growth %	96.54	-6.61	-90.92	-100	-
Normalized Net Income, 1 Yr. Growth %	86.37	-14.74	-87.89	-112.28	-4.15T
Diluted EPS Before Extra, 1 Yr. Growth %	-	-	-90.91	-	-
Accounts Receivable, 1 Yr. Growth %	-1.25	4.12	13.79	-15.68	13.74
Inventory, 1 Yr. Growth %	-14.64	5.88	27.12	3.7	1.61
Net Property, Plant and Equip., 1 Yr. Growth %	-6.84	-1.5	-2.84	7.46	39.84
Total Assets, 1 Yr. Growth %	-2.25	0.09	10.67	2.45	10.67
Tangible Book Value, 1 Yr. Growth %	-36.37	-87.13	253.85	54.35	-36.36
Common Equity, 1 Yr. Growth %	5.68	7.3	-1.18	-5.58	14.96
Cash From Operations, 1 Yr. Growth %	23.32	-9.68	-70.4	81.22	142.99
Capital Expenditures, 1 Yr. Growth %	38.5	-11.18	30.94	10.99	22.03
Levered Free Cash Flow, 1 Yr. Growth %	-	16.42	28.09	-36.23	48.36
Unlevered Free Cash Flow, 1 Yr. Growth %	-	17.6	34.72	-29.4	36.15
Dividend Per Share, 1 Yr. Growth %	-	-	-	23.9	52.37
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-	-1.84	1.54	5.63	5.74
Gross Profit, 2 Yr. CAGR %	-	-0.91	-0.38	6.07	7.76
EBITDA, 2 Yr. CAGR %	-	7	-34.31	-33.5	54.37
EBITA, 2 Yr. CAGR %	-	11.65	-39.08	-38.14	67.28
EBIT, 2 Yr. CAGR %	-	24.29	-48.13	-50.22	96.3
Earnings From Cont. Operations, 2 Yr. CAGR %	-	35.35	-70.35	-96.57	238.01
Net Income, 2 Yr. CAGR %	-	35.48	-70.88	-	244.53
Normalized Net Income, 2 Yr. CAGR %	-	26.06	-67.87	-87.81	202.72
Diluted EPS Before Extra, 2 Yr. CAGR %	-	-	-	-	241.6
Accounts Receivable, 2 Yr. CAGR %	-	1.4	8.85	-2.04	-2.07
Inventory, 2 Yr. CAGR %	-	-4.93	16.02	14.82	2.65
Net Property, Plant and Equip., 2 Yr. CAGR %	-	-4.21	-2.17	2.18	22.58
Total Assets, 2 Yr. CAGR %	-	-1.09	5.24	6.48	6.49
Tangible Book Value, 2 Yr. CAGR %	-	-71.38	-32.51	133.7	-0.89
Common Equity, 2 Yr. CAGR %	-	6.48	2.97	-3.4	4.19
Cash From Operations, 2 Yr. CAGR %	-	5.54	-48.29	-26.76	109.84
Capital Expenditures, 2 Yr. CAGR %	-	10.91	7.84	20.55	16.38
Levered Free Cash Flow, 2 Yr. CAGR %	-	-	22.12	-9.62	-3.41
Unlevered Free Cash Flow, 2 Yr. CAGR %	-	-	25.87	-2.47	-2.5
Dividend Per Share, 2 Yr. CAGR %	-	-	-	-	37.4
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-	-	1.1	2.37	6.23
Gross Profit, 3 Yr. CAGR %	-	-	0.78	2.32	6.58
EBITDA, 3 Yr. CAGR %	-	-	-18.19	-26.39	4.46
EBITA, 3 Yr. CAGR %	-	-	-19.78	-30	5.04
EBIT, 3 Yr. CAGR %	-	-	-22.38	-39.61	5.26
Earnings From Cont. Operations, 3 Yr. CAGR %	-	-	-44.34	-89.68	2.45
Net Income, 3 Yr. CAGR %	-	-	-44.97	-	2.53
Normalized Net Income, 3 Yr. CAGR %	-	-	-42.27	-76.69	3.52
Diluted EPS Before Extra, 3 Yr. CAGR %	-	-	-	-	1.99
Accounts Receivable, 3 Yr. CAGR %	-	-	5.37	-0.03	2.96
Inventory, 3 Yr. CAGR %	-	-	4.74	11.76	10.23
Net Property, Plant and Equip., 3 Yr. CAGR %	-	-	-3.75	0.94	13.45
Total Assets, 3 Yr. CAGR %	-	-	2.68	4.31	7.86
Tangible Book Value, 3 Yr. CAGR %	-	-	-33.82	-11.08	51.47
Common Equity, 3 Yr. CAGR %	-	-	3.87	0.04	2.37
Cash From Operations, 3 Yr. CAGR %	-	-	-30.92	-21.46	9.23
Capital Expenditures, 3 Yr. CAGR %	-	-	17.22	8.88	21.04
Levered Free Cash Flow, 3 Yr. CAGR %	-	-	-	-1.66	6.12
Unlevered Free Cash Flow, 3 Yr. CAGR %	-	-	-	3.81	8.59
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-	-	-	-	2.93
Gross Profit, 5 Yr. CAGR %	-	-	-	-	3.52
EBITDA, 5 Yr. CAGR %	-	-	-	-	5.47
EBITA, 5 Yr. CAGR %	-	-	-	-	7.63
EBIT, 5 Yr. CAGR %	-	-	-	-	12.5
Earnings From Cont. Operations, 5 Yr. CAGR %	-	-	-	-	14.52
Net Income, 5 Yr. CAGR %	-	-	-	-	14.62
Normalized Net Income, 5 Yr. CAGR %	-	-	-	-	12.01
Accounts Receivable, 5 Yr. CAGR %	-	-	-	-	2.33
Inventory, 5 Yr. CAGR %	-	-	-	-	3.9
Net Property, Plant and Equip., 5 Yr. CAGR %	-	-	-	-	6.02
Total Assets, 5 Yr. CAGR %	-	-	-	-	4.19
Tangible Book Value, 5 Yr. CAGR %	-	-	-	-	-22.22
Common Equity, 5 Yr. CAGR %	-	-	-	-	3.99
Cash From Operations, 5 Yr. CAGR %	-	-	-	-	7.74
Capital Expenditures, 5 Yr. CAGR %	-	-	-	-	16.88